報價延遲最少15分鐘:2025/11/27 13:12 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
368.53 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
9.74/19.56
|
|
企業價值
76.47B
|
| 資產負債 |
|
每股賬面淨值
9.01
|
| 現金流量 |
|
現金流量率
0.05
|
| 損益表 |
|
收益
293.96B
|
|
每股收益
1,312.30
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe. |
